Adma Biologics reported $151.97M in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Adamis Pharmaceuticals ADMP:US USD -808070 3.81M
Adma Biologics ADMA:US USD 151.97M 51.59M
Agile Therapeutics AGRX:US USD -5545000 11.8M
Alnylam Pharmaceuticals ALNY:US USD -158223000 90.58M
Biocryst Pharmaceuticals BCRX:US USD -294597000 51.94M
Dynavax Technologies DVAX:US USD 581.01M 80.44M
Minerva Neurosciences NERV:US USD -20024000 5.78M
Novavax NVAX:US USD -634078000 68.09M
Omeros OMER:US USD 85.68M 132M
Takeda 4502:JP JPY 6.18T 536.95B